<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infectious causes of neutropenia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infectious causes of neutropenia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infectious causes of neutropenia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas D Coates, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter Newburger, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan G Rosmarin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 02, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Neutropenia can be caused by infection with microorganisms. Conversely, neutropenia can lead to infection, typically from bacterial organisms. A number of different mechanisms are involved, including infection of hematopoietic precursor cells, infection of endothelial cells, increased neutrophil adherence to endothelium, development of antineutrophil antibodies, and enhanced neutrophil utilization at the site of infection associated with hypersplenism. Drugs given to treat these infections may also cause neutropenia. (See  <a class="medical medical_review" href="/z/d/html/8374.html" rel="external">"Drug-induced neutropenia and agranulocytosis"</a>.)</p><p>This review will discuss the neutropenias that can occur during bacterial, viral, parasitic, or rickettsial infections. Approaches to determining the cause of unexplained neutropenia in children and adults are presented separately. (See  <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">"Overview of neutropenia in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia"</a>.)</p><p>Infections in patients with neutropenia can range from mild to life-threatening, depending on the cause of the neutropenia. Fever in a neutropenic patient is considered a medical emergency unless the patient is known to be low risk. This issue is discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16708.html" rel="external">"Overview of neutropenic fever syndromes"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6058.html" rel="external">"Evaluation of children with non-chemotherapy-induced neutropenia and fever"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">"Management of children with non-chemotherapy-induced neutropenia and fever"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16888.html" rel="external">"Risk assessment of adults with chemotherapy-induced neutropenia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16139.html" rel="external">"Diagnostic approach to the adult cancer patient with neutropenic fever"</a>.)</p><p></p><p class="headingAnchor" id="H1155994"><span class="h1">DEFINITIONS AND INFECTIOUS RISK</span><span class="headingEndMark"> — </span>Neutropenia is defined as an absolute neutrophil count (ANC) of less than 1500/microL. The ANC is equal to the product of the white blood cell count (WBC) and the percentage of polymorphonuclear cells (PMNs) and band forms noted on the differential analysis:</p><p>      ANC  =  WBC (cells/microL)  x  percent (PMNs  +  bands)  ÷  100 (<a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">calculator 1</a>)</p><p>Neutrophilic metamyelocytes and younger forms are not included in this calculation. The risk of infection begins to increase at an ANC below 1000/microL  (<a class="graphic graphic_table graphicRef63903" href="/z/d/graphic/63903.html" rel="external">table 1</a>).</p><p>Leukopenia and granulocytopenia are generally used interchangeably with neutropenia, although they are somewhat different. Leukopenia refers to a low WBC that may be due to lymphopenia as well as neutropenia, while granulocytopenia refers to a reduced number of granulocytes (neutrophils, eosinophils, and basophils). Agranulocytosis literally means the absence of granulocytes, but the term is often used to indicate severe neutropenia (ie, ANC less than 500/microL).</p><p>Most cases of neutropenia are acquired and are due to decreased granulocyte production or increased destruction. Acquired neutropenia is most often due to accelerated turnover, usually resulting from immunologic mechanisms. The key questions that arise in the patient with infection and neutropenia are:</p><p class="bulletIndent1"><span class="glyph">●</span>Is the patient infected because of the neutropenia?</p><p class="bulletIndent1"><span class="glyph">●</span>Is the patient neutropenic because of the infection?</p><p class="bulletIndent1"><span class="glyph">●</span>Are the two events totally unrelated?</p><p></p><p>The critical clinical question is whether or not the patient is at increased risk of overwhelming infection because of the neutropenia, as this will determine the immediate management of the infection. The propensity to infection from neutropenia is related to the adequacy of the bone marrow reserve pool and other factors such as presence of vasculitis or immune deficiency. Certain patients with normal marrow reserve and an ANC of zero may be at no increased risk because of the neutropenia. These distinctions are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">"Overview of neutropenia in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia", section on 'Risk of infection'</a>.)</p><p class="headingAnchor" id="H1361790561"><span class="h1">VIRAL INFECTION</span><span class="headingEndMark"> — </span>Viral infections that can present with neutropenia include human immunodeficiency virus (HIV), infectious mononucleosis, cytomegalovirus (CMV), hepatitis A, and the viral exanthematous diseases. A review of 259 viral infections associated with febrile neutropenia in Vietnamese children reported 50 percent due to influenza A, 31 percent influenza B, 15 percent dengue, measles 1.9 percent, rotavirus 1.5 percent, and Epstein-Barr virus (EBV) 0.4 percent. Only 11 percent had an absolute neutrophil count (ANC) &lt;500/microL [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H3493579771"><span class="h2">Common childhood viral infections</span><span class="headingEndMark"> — </span>Transient mild to moderate neutropenia can be caused by a variety of common viral infections during childhood, including respiratory syncytial virus (RSV), influenza A and B, and parvovirus. In most cases, neutropenia occurs during the first few days of the viral illness and persists for three to eight days [<a href="#rid2">2</a>]. Similar patterns may occur after Epstein-Barr virus (EBV) and human herpes virus 6 (HHV-6) infections, as discussed below.</p><p class="headingAnchor" id="H2697031420"><span class="h2">Coronavirus disease 2019 (COVID-19)</span><span class="headingEndMark"> — </span>While infection with CARS-Cov-2 is primarily a respiratory illness, there are significant hematological manifestations and substantial inflammation. Patients usually have leukocytosis at the onset [<a href="#rid3">3</a>]. However, there have been several cases of associated aplastic anemia and/or transient neutropenia [<a href="#rid4">4</a>]. Leukopenia occurs in 17 to 33 percent of patients, but it is primarily due to lymphopenia [<a href="#rid5">5</a>]. Bone marrow aspirates in two cases of neutropenia during COVID showed normal cellularity [<a href="#rid4">4,6</a>]. Severe neutropenia appears to be a relatively uncommon manifestation of COVID-19. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features", section on 'Laboratory findings'</a>.)</p><p class="headingAnchor" id="H1635755931"><span class="h2">HIV</span><span class="headingEndMark"> — </span>A variety of hematologic abnormalities are associated with infection by HIV. Anemia, neutropenia, and thrombocytopenia are seen with increasing prevalence as the disease becomes more severe [<a href="#rid7">7-9</a>]. Neutropenia is seen in approximately 40 percent of patients with AIDS [<a href="#rid10">10</a>] either on an autoimmune basis [<a href="#rid11">11</a>] or as a side effect of drug therapy [<a href="#rid12">12</a>]. Lymphopenia occurs in 75 percent of patients due primarily to the fall in the CD4 cell count [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/8374.html" rel="external">"Drug-induced neutropenia and agranulocytosis"</a>.)</p><p>There is a significantly higher risk of hospitalization for bacterial infection among HIV-infected patients with neutropenia, as illustrated by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>In one series of 2047 patients, the risk for developing a bacterial infection requiring hospitalization occurred at absolute neutrophil counts (ANCs) below 750/microL and increased progressively as the ANC fell below this level  (<a class="graphic graphic_figure graphicRef81371" href="/z/d/graphic/81371.html" rel="external">figure 1</a>) [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a case-controlled study, the adjusted relative risk for the occurrence of bacterial infection was 2.3 for patients with an ANC below 1000/microL and 7.9 for those with an ANC below 500/microL [<a href="#rid9">9</a>]. The incidence of severe infection was 3 to 5 per 100 patient-months at an ANC below 500/microL.</p><p></p><p>Increasing the ANC by the administration of granulocyte colony-stimulating factor (G-CSF; <a class="drug drug_general" data-topicid="8446" href="/z/d/drug information/8446.html" rel="external">filgrastim</a>) or granulocyte-monocyte colony-stimulating factor (GM-CSF; <a class="drug drug_general" data-topicid="9878" href="/z/d/drug information/9878.html" rel="external">sargramostim</a>) reduces the incidence of infection in patients with advanced HIV disease [<a href="#rid13">13-15</a>]. As an example, a multicenter trial randomized 258 HIV-infected patients with a CD4 cell count below 200/microL and an ANC between 750 and 1000/microL to placebo or increasing doses of daily or intermittent filgrastim to maintain an ANC between 2000 and 10,000/microL [<a href="#rid14">14</a>]. The incidence of severe neutropenia or death was much lower in the treated patients (10 versus 34 percent) who also had 31 percent fewer bacterial infections.</p><p class="headingAnchor" id="H1854451273"><span class="h2">Epstein-Barr virus</span><span class="headingEndMark"> — </span>EBV infection produces an acute sporadic infection called infectious mononucleosis (IM) that usually affects young adults. Clinical manifestations of IM include fever, severe pharyngitis, adenopathy, and splenomegaly.</p><p>EBV infects B lymphocytes resulting in peripheral blood lymphocytosis with many "atypical" lymphocytes and antibodies against heterologous red cells and EBV. Antineutrophil antibodies may be seen during acute IM, resulting in either a transient PMN aggregation or severe neutropenia [<a href="#rid16">16,17</a>]; the latter is more common in children [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H483289487"><span class="h2">Cytomegalovirus</span><span class="headingEndMark"> — </span>CMV infection produces fever, sore throat, adenopathy, splenomegaly, and myalgias in otherwise healthy individuals. It is also a major cause of morbidity and mortality in patients with AIDS and in hematopoietic stem cell or solid organ transplant recipients. The blood picture resembles IM except for the absence of IM-associated antibodies. Neutropenia is not part of uncomplicated CMV infection but can occur after the administration of <a class="drug drug_general" data-topicid="8485" href="/z/d/drug information/8485.html" rel="external">ganciclovir</a> or in disseminated disease in immunosuppressed patients [<a href="#rid19">19-21</a>].</p><p class="headingAnchor" id="H2952572769"><span class="h2">Hepatitis virus group</span><span class="headingEndMark"> — </span>Hepatitis A virus infection is associated with transient neutropenia and lymphopenia that usually occur during the second week of illness [<a href="#rid22">22</a>]. The hematologic manifestations can be severe and are independent of the severity of liver disease. Agranulocytosis has been described [<a href="#rid23">23</a>].</p><p>Neutropenia can be seen in patients with chronic hepatitis B or C infection. It is usually related to the development of cirrhosis and hypersplenism, or treatment with interferon alfa [<a href="#rid24">24,25</a>].</p><p>Aplastic anemia is a rare complication of hepatitis but may account for 2 to 5 percent of cases of aplastic anemia in the West [<a href="#rid26">26,27</a>]. The mechanism may involve T cell activation with release of cytokines. The disease most often affects boys and young men, with aplasia developing two to three months after an episode of acute hepatitis [<a href="#rid26">26</a>]. The responsible virus has not been identified; neither hepatitis A, B, C, nor G appears to be involved [<a href="#rid26">26,28</a>]. (See  <a class="medical medical_review" href="/z/d/html/7152.html" rel="external">"Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3934459931"><span class="h2">Human herpesvirus 6</span><span class="headingEndMark"> — </span>HHV-6 infection can cause leukopenia in association with roseola infantum in children or after organ transplantation [<a href="#rid29">29,30</a>]. In one report of four liver transplant recipients, severe cytopenia was seen in all patients with leukopenia being most prominent (mean 1400/microL) [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H4286062301"><span class="h2">Viral exanthematous diseases</span><span class="headingEndMark"> — </span>Leukopenia and mild neutropenia and lymphopenia are common in infections with measles, rubella, and varicella.</p><p class="headingAnchor" id="H1226098564"><span class="h3">Measles</span><span class="headingEndMark"> — </span>During the incubation period in measles, there may be leukocytosis with a white blood cell count of 14,000 to 19,000/microL lasting three days before the onset of fever. This is followed by leukopenia during the week of cough, coryza, conjunctivitis, Koplik spots and rash [<a href="#rid31">31</a>]. The mean ANC varies widely from 2000 to 8000/microL during the incubation period and falls to less than 500 to 5000/microL with the nadir occurring at the onset of the rash  (<a class="graphic graphic_figure graphicRef65459" href="/z/d/graphic/65459.html" rel="external">figure 2</a>).</p><p>Measles virus antigen is localized in circulating neutrophils [<a href="#rid32">32</a>] and neutrophil functions of chemotaxis and bacterial killing are impaired during active infection [<a href="#rid33">33-35</a>]. (See  <a class="medical medical_review" href="/z/d/html/8388.html" rel="external">"Laboratory evaluation of neutrophil disorders"</a>.)</p><p>Live measles virus vaccine also results in transient decrease in white blood cell count from day 3 to day 16 after vaccination. Mild neutropenia is evident by day 8 when low grade fever occurs and returns to baseline two weeks after vaccination [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H2778362175"><span class="h3">Rubella</span><span class="headingEndMark"> — </span>Neutropenia occurs in one-third to one-half of patients with rubella and slowly recedes over six weeks [<a href="#rid37">37</a>]. Changes in lymphocyte count are variable, ranging from lymphocytosis to, less often, lymphopenia.</p><p class="headingAnchor" id="H2256626204"><span class="h3">Varicella</span><span class="headingEndMark"> — </span>Varicella infection is usually associated with mild leukocytosis and neutrophilia [<a href="#rid38">38</a>]. However, profound leukopenia and neutropenia of less than 1000/microL with an associated increase in band forms has been described [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H3585244497"><span class="h2">Other</span><span class="headingEndMark"> — </span>Neutropenia can occur during the course of a number of other viral infections. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Dengue fever virus, in which leukopenia, thrombocytopenia, and a hemorrhagic diathesis are the typical hematologic findings; a low white blood cell count is apparent early in the illness, reaching a nadir after seven days of fever and then returning to normal by the end of two weeks [<a href="#rid40">40,41</a>]. A direct action of dengue virus on the bone marrow is thought to be responsible. (See  <a class="medical medical_review" href="/z/d/html/3029.html" rel="external">"Dengue virus infection: Pathogenesis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Colorado tick fever virus, in which leukopenia (1800 to 3400/microL) is the major laboratory finding [<a href="#rid42">42</a>]. The differential shows increased band forms and occasional metamyelocytes and myelocytes, and bone marrow examination reveals depletion of the normal reserve of neutrophils, so called "myeloid arrest." The virus infects human bone marrow hematopoietic progenitor cells and the leukopenia is thought to reflect a direct toxic action on the marrow [<a href="#rid43">43,44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Yellow fever, in which neutropenia occurs during the first week of infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Phlebotomus fever virus, in which an initial leukopenia is followed by a protracted neutropenia [<a href="#rid45">45,46</a>].</p><p></p><p class="headingAnchor" id="H2"><span class="h1">BACTERIAL INFECTION</span><span class="headingEndMark"> — </span>Leukocytosis with an increased number of band forms (ie, a shift to the left) is the usual response to bacterial infection. Certain infections, however, such as typhoid fever, <em>Shigella </em>enteritis, brucellosis, tularemia, and tuberculosis are often associated with neutropenia.</p><p class="headingAnchor" id="H3"><span class="h2">Typhoid fever</span><span class="headingEndMark"> — </span>Typhoid fever is a severe systemic illness characterized by sustained fever and abdominal symptoms. Leukopenia with neutropenia and an increased percentage of band forms is seen in approximately 25 to 50 percent of adults with this disorder [<a href="#rid47">47</a>]. Thrombocytopenia and anemia are even more frequent, while pancytopenia is found in less than 10 percent of cases [<a href="#rid48">48</a>].</p><p>Several consequences of infection in the early phase of the disease contribute to the neutropenia:</p><p class="bulletIndent1"><span class="glyph">●</span>The bone marrow shows granulocytic hyperplasia with hemophagocytosis followed by granuloma in the later phases [<a href="#rid49">49,50</a>]. Hemophagocytosis, if extensive, contributes to peripheral blood cytopenia [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Plasma concentrations of endotoxin, tumor necrosis factor (TNF)-receptors, interleukin (IL)-6, and interferon-gamma, blood leukocyte expression of TNF-alpha and IL-1 beta genes, and extracellular phospholipase A2 are elevated. These mediators of inflammation up-regulate expression of vascular endothelial cell adhesion molecules and shift circulating PMNs onto sticky endothelium [<a href="#rid52">52-56</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Shigella enteritis</span><span class="headingEndMark"> — </span>The white blood cell (WBC) count varies widely from leukopenia to leukocytosis in both children and adults with <em>Shigella</em> enteritis, but a striking shift to the left (increased percentage of band forms) is a common feature that helps to distinguish this disorder from <em>Salmonella</em> infection or viral enteritis [<a href="#rid57">57,58</a>].</p><p>The mechanism by which <em>Shigella</em> infection causes neutropenia is not well understood. The outer membrane proteins from two antigenically different strains of <em>Shigella</em> (<em>Shigella flexneri</em> and <em>Shigella sonnei</em>) caused fever and leukopenia followed by transient leukocytosis when injected intravenously into rabbits [<a href="#rid59">59</a>].</p><p>Shigellosis can be associated with a number of systemic complications such as septicemia, hemolytic-uremic syndrome, and a leukemoid reaction (see  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis"</a>). Polymorphonuclear cells (PMNs) from children with complicated Shigellosis are more likely to be activated (as determined by in vitro testing) than PMNs from children with uncomplicated Shigellosis [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/8388.html" rel="external">"Laboratory evaluation of neutrophil disorders"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Brucellosis</span><span class="headingEndMark"> — </span>Neutropenia occurs in 20 to 30 percent of adults and children with brucellosis [<a href="#rid61">61-63</a>]. Most of these patients are anemic and up to 20 percent are pancytopenic [<a href="#rid62">62,64</a>].</p><p>Hypersplenism, hemophagocytosis by marrow macrophages (which correlates with hypersplenism), and granulomatous lesions of the bone marrow appear to contribute to the development of these abnormalities [<a href="#rid64">64-66</a>]. <em>Brucella melitensis</em> can almost always be cultured from the bone marrow during the acute stage of the infection [<a href="#rid65">65</a>]. In addition, in one report of 16 patients with pancytopenia who underwent bone marrow biopsy, noncaseating granulomas were present in eleven [<a href="#rid64">64</a>].</p><p>Intravenous injection of mice with <em>Brucella abortus</em> results in a similar type of chronic infection with splenomegaly characterized by massive numbers of macrophages [<a href="#rid67">67</a>]. Cases of reactive hemophagocytosis with clinical features of fever, wasting, splenomegaly, and pancytopenia have been associated with Brucellosis [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Tularemia</span><span class="headingEndMark"> — </span>Tularemia is a zoonosis caused by the Gram negative, facultative intracellular coccobacillus, Francisella tularensis. Clinical manifestations are varied and include ulceroglandular disease and pneumonia (see  <a class="medical medical_review" href="/z/d/html/3141.html" rel="external">"Tularemia: Clinical manifestations, diagnosis, treatment, and prevention"</a>). The mean WBC and differential are usually normal, as neutropenia occurs in only a small percentage of patients [<a href="#rid69">69,70</a>].</p><p>PMNs are essential for host defense against primary infection in tularemia. Mice rendered agranulocytic by treatment with a granulocyte specific antibody and then infected with <em>Francisella tularensis</em> became lethally infected in their lungs, liver, and spleen [<a href="#rid71">71</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Tuberculosis</span><span class="headingEndMark"> — </span>Hematologic abnormalities are common in patients with hematogenously disseminated miliary tuberculosis. In one study of 109 such patients, the WBC was less than 4000/microL in 15 percent, and 87 percent were lymphopenic with absolute lymphocyte counts less than 1500/microL. Neutropenia was seen as part of pancytopenia in six patients [<a href="#rid72">72</a>]. In another series of 380 patients with pulmonary tuberculosis, leukopenia with neutropenia and lymphopenia was observed in 16 percent of those with very severe disease [<a href="#rid73">73</a>].</p><p class="headingAnchor" id="H11"><span class="h1">RICKETTSIAL INFECTION</span><span class="headingEndMark"> — </span>Neutropenia is common in rickettsialpox and human granulocytic anaplasmosis; it is also seen in severe cases of Rocky Mountain spotted fever.</p><p class="headingAnchor" id="H13108612"><span class="h2">Rickettsialpox</span><span class="headingEndMark"> — </span>Leukopenia occurs in approximately 75 percent of patients with rickettsialpox [<a href="#rid74">74</a>]. Although the differential count is usually normal, there is a relative lymphocytosis in some patients and a left shift of band forms in others. (See  <a class="medical medical_review" href="/z/d/html/7909.html" rel="external">"Rickettsialpox"</a>.)</p><p class="headingAnchor" id="H13108650"><span class="h2">Human granulocytic anaplasmosis</span><span class="headingEndMark"> — </span>Human granulocytic anaplasmosis (HGA; previously called human granulocytic ehrlichiosis) is a rickettsial infection transmitted by tick bite. The vector is <em>Ixodes scapularis</em>, which is also the vector for Lyme disease. The spectrum of clinical presentations is wide, and symptoms may be nonspecific. The organism infects neutrophils, which are unable to kill it following internalization; monocytes appear to be resistant [<a href="#rid75">75,76</a>]. Neutropenia and/or lymphopenia are often seen; thrombocytopenia is also common [<a href="#rid77">77,78</a>]. (See  <a class="medical medical_review" href="/z/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis", section on 'Human granulocytic anaplasmosis'</a> and  <a class="medical medical_review" href="/z/d/html/7903.html" rel="external">"Biology of Anaplasmataceae"</a>.) </p><p class="headingAnchor" id="H13108681"><span class="h2">Rocky Mountain spotted fever</span><span class="headingEndMark"> — </span>Most cases of Rocky Mountain spotted fever (RMSF) are associated with a normal white blood cell count or leukocytosis [<a href="#rid79">79</a>]. However, leukopenia and neutropenia can occur in patients with severe disease associated with occlusive fibrin microthrombosis, shock, and multiple organ failure. (See  <a class="medical medical_review" href="/z/d/html/7904.html" rel="external">"Clinical manifestations and diagnosis of Rocky Mountain spotted fever"</a>.)</p><p class="headingAnchor" id="H676494"><span class="h1">PARASITIC INFESTATION</span><span class="headingEndMark"> — </span>Kala-azar and malaria are two parasitic infections with characteristic neutropenia.</p><p class="headingAnchor" id="H676517"><span class="h2">Kala-azar</span><span class="headingEndMark"> — </span>Infection with <em>Leishmania donovani</em> causes fever, hepatosplenomegaly, and neutropenia as part of pancytopenia. All patients have anemia and approximately 43 percent later develop neutropenia. The disease occurs in individuals who have resided in endemic areas (Mediterranean countries, India, East Africa, South America). There is also a hemolytic anemia that may in part be due to the generation of oxidative metabolic products. (See  <a class="medical medical_review" href="/z/d/html/7168.html" rel="external">"Non-immune (Coombs-negative) hemolytic anemias in adults"</a>.)</p><p>Several mechanisms contribute to the neutropenia. Leukokinetic studies on two patients with kala-azar found that the polymorphonuclear cell (PMN) half-life was reduced with shifts of circulating PMNs to pooling and destruction in an enlarged spleen and, to a lesser extent, in the liver [<a href="#rid80">80</a>]. (See  <a class="medical medical_review" href="/z/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia", section on 'Mechanisms'</a>.)</p><p>While the bone marrow reserve of PMNs has been noted to be markedly reduced in some [<a href="#rid80">80</a>], in general the marrow shows myeloid hyperplasia and increased megakaryocytes [<a href="#rid81">81</a>]. Rapid destruction of antibody-coated blood cells could contribute to the pancytopenia. Immunologic studies of the pancytopenia in one series revealed membrane-associated antiplatelet, antineutrophil, and antierythrocyte IgG antibodies [<a href="#rid82">82</a>].</p><p>The size of the spleen, hemoglobin level, platelet level and number of bone marrow plasma cells are related to the parasite load. The degree of parasitization, spleen size, and duration of illness generally correlate with the severity of the pancytopenia [<a href="#rid83">83</a>]. Amastigote forms of <em>Leishmania donovani</em> are found in bone marrow macrophages, PMNs, and eosinophils in 60 to 85 percent of cases [<a href="#rid84">84</a>] but the yield is close to 100 percent if the bone marrow aspirate is cultured and then evaluated [<a href="#rid85">85</a>]. A likely contributor to the anemia is hyperactive bone marrow macrophages which phagocytose immature erythroblasts and cause ineffective erythropoiesis [<a href="#rid81">81,86</a>].</p><p>The marked leukopenia in visceral leishmaniasis contributes to secondary infections. Susceptibility to secondary infection can be significantly reduced by treatment with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). The effects of GM-CSF on neutropenia and the rate of infection were evaluated in 24 patients with an absolute neutrophil count (ANC) less than 1500/microL [<a href="#rid87">87</a>]. Patients treated with GM-CSF for 10 days, with pentavalent antimony given daily for 20 days, experienced a three- to fourfold increase in ANC at day 5 and 10, respectively. The incidence of secondary infection was reduced in the patients randomly assigned to treatment with to GM-CSF (21 versus 80 percent with placebo). Importantly, all patients, regardless of treatment, had complete resolution of leishmaniasis at three months.</p><p class="headingAnchor" id="H676523"><span class="h2">Malaria</span><span class="headingEndMark"> — </span>Mild neutropenia is common in malarial infection although neutrophilia occurs in severe disease. The hyperreactive malarial splenomegaly syndrome (also called the tropical splenomegaly syndrome) occurs throughout Africa, India, and Southeast Asia. It is associated with massive splenomegaly, pancytopenia, high levels of malarial antibodies, and hyper-IgM syndrome, which resolves after prolonged antimalarial therapy [<a href="#rid88">88</a>]. In one series, neutropenia was seen in 7 percent of patients on admission; individuals who developed severe neutropenia were more likely to do so later during the hospitalization than at presentation [<a href="#rid89">89</a>].</p><p>The mechanism of the neutropenia has been studied in six subjects with untreated malaria due to <em>Plasmodium vivax</em> and a mean ANC of 1700/microL; all had moderate splenomegaly [<a href="#rid90">90</a>]. The number of circulating band forms was increased, the PMN half-life was prolonged, and the total blood granulocyte pool was normal or increased. The marginating PMN pool was greatly enlarged while the circulating PMN pool was reduced, indicating that the apparent neutropenia was due to a shift of circulating PMN into the marginating pool primarily in the spleen and lung. These patients had decreased numbers and reserves of bone marrow PMNs, presumably due to their premature release into the circulation. (See  <a class="medical medical_review" href="/z/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia", section on 'Mechanisms'</a>.)</p><p>There is some evidence that sequestration of CD11a–bearing PMNs, due to tumor necrosis factor-induced upregulation of the endothelial expression of intercellular adhesion molecule (ICAM)-1, contributes to the mortality and microvascular lesions with severe malaria. In an experimental model in which mice were infected with murine malaria, the administration of a monoclonal antibody against PMN induced profound neutropenia, abolished PMN sequestration in the lung, and prevented mortality [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H4000910643"><span class="h1">HEMOPHAGOCYTIC SYNDROME SECONDARY TO INFECTION</span><span class="headingEndMark"> — </span>Hemophagocytic lymphohistiocytosis (HLH) is a severe, potentially life-threatening syndrome of excess immune activation that can be triggered by numerous viral, bacterial, parasitic, and fungal infections. Epstein-Barr virus, cytomegalovirus, parvovirus, and herpes simplex virus are infections that are most often associated with severe forms of HLH, especially in association with genetic variants of genes that involve immune regulation. HLH is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis", section on 'Infections'</a>.)</p><p class="headingAnchor" id="H16373173"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/82906.html" rel="external">"Patient education: Neutropenia (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H13221343"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Description</strong> – Neutropenia is defined as an absolute neutrophil count (ANC) of less than 1500/microL (<a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">calculator 1</a>). (See <a class="local">'Definitions and infectious risk'</a> above.)</p><p></p><p class="bulletIndent1">There is nothing diagnostically specific about the presence of neutropenia in response to infection. The first question to be answered is: "Is the infection due to the neutropenia, or is the neutropenia from the infection?" The differential diagnosis and approach to evaluation of neutropenia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">"Overview of neutropenia in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral infection</strong> – Neutropenia can be seen in a large number of viral infections. The mechanisms differ widely, and include antineutrophil antibodies, hypersplenism, infection-induced bone marrow suppression or aplasia, and toxicity of the drugs used to fight the infection. (See <a class="local">'Viral infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial infections</strong> – Leukocytosis with an increased number of band forms (ie, a shift to the left) is the usual response to bacterial infection. Certain infections such as typhoid fever, <em>Shigella</em> enteritis, brucellosis, tularemia, and tuberculosis are often associated with neutropenia. Hypersplenism, hemophagocytosis by marrow macrophages, and granulomatous lesions of the bone marrow contribute to the development of these abnormalities. (See <a class="local">'Bacterial infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rickettsial infection</strong> – Neutropenia is common in rickettsialpox and human granulocytic anaplasmosis (previously called human granulocytic ehrlichiosis) and is also seen in severe cases of Rocky Mountain spotted fever. Peripheral destruction appears to be the most common mechanism. (See <a class="local">'Rickettsial infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parasitic infestation</strong> – Both kala-azar and malaria can be associated with neutropenia, often secondary to sequestration of neutrophils within an enlarged spleen. (See <a class="local">'Parasitic infestation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemophagocytic syndrome</strong> – Neutropenia (with or without other cytopenias) can occur in the setting of hemophagocytic lymphohistiocytosis (HLH), which is often triggered by an acute infection. (See  <a class="medical medical_review" href="/z/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis"</a>.)</p><p></p><p class="headingAnchor" id="H2076768999"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges the late Laurence A Boxer, MD, for his previous role as a section editor for this topic.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nguyen SN, Vu LT, Vu QV, et al. Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases. Hematol Rep 2022; 14:245.</a></li><li><a class="nounderline abstract_t">Segel GB, Halterman JS. Neutropenia in pediatric practice. Pediatr Rev 2008; 29:12.</a></li><li><a class="nounderline abstract_t">Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26:1017.</a></li><li><a class="nounderline abstract_t">Wu K, Dansoa Y, Pathak P. Pancytopenia with Development of Persistent Neutropenia Secondary to COVID-19. Case Rep Hematol 2022; 2022:8739295.</a></li><li><a class="nounderline abstract_t">Singh R, Ratre BK, Sirohiya P, Bhatnagar S. Self-limiting severe neutropenia in a patient with COVID-19. BMJ Case Rep 2021; 14.</a></li><li><a class="nounderline abstract_t">Hernandez JM, Quarles R, Lakshmi S, et al. Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement. Open Forum Infect Dis 2021; 8:ofab017.</a></li><li><a class="nounderline abstract_t">Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol 1987; 66:251.</a></li><li><a class="nounderline abstract_t">Jacobson MA, Liu RC, Davies D, Cohen PT. Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection. Arch Intern Med 1997; 157:1825.</a></li><li><a class="nounderline abstract_t">Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995; 155:1965.</a></li><li><a class="nounderline abstract_t">Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987; 66:337.</a></li><li><a class="nounderline abstract_t">Ribera E, Ocaña I, Almirante B, et al. Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect 1989; 18:167.</a></li><li><a class="nounderline abstract_t">Perkocha LA, Rodgers GM. Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol 1988; 29:94.</a></li><li><a class="nounderline abstract_t">Scadden DT, Bering HA, Levine JD, et al. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol 1991; 9:802.</a></li><li><a class="nounderline abstract_t">Kuritzkes DR, Parenti D, Ward DJ, et al. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. AIDS 1998; 12:65.</a></li><li><a class="nounderline abstract_t">Manfredi R, Mastroianni A, Coronado O, Chiodo F. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease. J Chemother 1996; 8:214.</a></li><li><a class="nounderline abstract_t">Schooley RT, Densen P, Harmon D, et al. Antineutrophil antibodies in infectious mononucleosis. Am J Med 1984; 76:85.</a></li><li><a class="nounderline abstract_t">Guibaud S, Plumet-Leger A, Frobert Y. Transient neutrophil aggregation in a patient with infectious mononucleosis. Am J Clin Pathol 1983; 80:883.</a></li><li><a class="nounderline abstract_t">Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985; 75:1011.</a></li><li><a class="nounderline abstract_t">Roberts WD, Weinberg KI, Kohn DB, et al. Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection. Am J Pediatr Hematol Oncol 1993; 15:320.</a></li><li><a class="nounderline abstract_t">Salzberger B, Bowden RA, Hackman RC, et al. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome. Blood 1997; 90:2502.</a></li><li><a class="nounderline abstract_t">Farrugia E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992; 67:879.</a></li><li><a class="nounderline abstract_t">HAVENS WP Jr, MARCK RE. The leukocytic response of patients with experimentally induced infectious hepatitis. Am J Med Sci 1946; 212:129.</a></li><li><a class="nounderline abstract_t">Nagaraju M, Weitzman S, Baumann G. Viral hepatitis and agranulocytosis. Am J Dig Dis 1973; 18:247.</a></li><li><a class="nounderline abstract_t">Rakela J, Wood JR, Czaja AJ, et al. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial. Mayo Clin Proc 1990; 65:1330.</a></li><li><a class="nounderline abstract_t">Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997; 26:112S.</a></li><li><a class="nounderline abstract_t">Brown KE, Tisdale J, Barrett AJ, et al. Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336:1059.</a></li><li><a class="nounderline abstract_t">Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1990; 75:1646.</a></li><li><a class="nounderline abstract_t">Issaragrisil S, Kaufman D, Thongput A, et al. Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology 1997; 25:1255.</a></li><li><a class="nounderline abstract_t">Linnavuori K, Peltola H, Hovi T. Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum). Pediatrics 1992; 89:103.</a></li><li><a class="nounderline abstract_t">Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997; 64:674.</a></li><li><a class="nounderline abstract_t">Benjamin B, Ward SM. Leukocytic response to measles. Am J Dis Child 1932; 44:921.</a></li><li><a class="nounderline abstract_t">Abramowitz A, Tamir I, Livni N, et al. Polymorphonuclear leukocyte-associated antigenemia in measles: demonstration and significance. J Med Virol 1984; 13:293.</a></li><li><a class="nounderline abstract_t">Yetgin S, Altay C. Defective bactericidal function of polymorphonuclear neutrophils in children with measles. Acta Paediatr Scand 1980; 69:411.</a></li><li><a class="nounderline abstract_t">Thatte UM, Gangal PS, Kulkarni MR, et al. Polymorphonuclear and monocyte functions in measles. J Trop Pediatr 1991; 37:67.</a></li><li><a class="nounderline abstract_t">Anderson R, Rabson AR, Sher R, Koornhof HJ. Defective neutrophil motility in children with measles. J Pediatr 1976; 89:27.</a></li><li><a class="nounderline abstract_t">Black FL, Sheridan SR. Blood leukocyte response to live measles vaccine. Am J Dis Child 1967; 113:301.</a></li><li><a class="nounderline abstract_t">HILLENBRAND FK. The blood picture in rubella; its place in diagnosis. Lancet 1956; 271:66.</a></li><li class="breakAll">Arvin AM. Varicella-Zoster virus. In: Nelson Textbook of Pediatrics, 15th ed, Behman RE, Kliegman RM, Arvin AM (Eds), WB Saunders, Philadelphia 1996.</li><li><a class="nounderline abstract_t">Koumbourlis AC, Heldrich FJ. Varicella infection with profound neutropenia, multisystem involvement and no sequelae. Pediatr Infect Dis J 1988; 7:429.</a></li><li><a class="nounderline abstract_t">Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313.</a></li><li><a class="nounderline abstract_t">Halstead SB. Dengue: hematologic aspects. Semin Hematol 1982; 19:116.</a></li><li><a class="nounderline abstract_t">JOHNSON ES, NAPOLI VM, WHITE WC. Colorado tick fever as a hematologic problem. Am J Clin Pathol 1960; 34:118.</a></li><li><a class="nounderline abstract_t">Philipp CS, Callaway C, Chu MC, et al. Replication of Colorado tick fever virus within human hematopoietic progenitor cells. J Virol 1993; 67:2389.</a></li><li><a class="nounderline abstract_t">Oshiro LS, Dondero DV, Emmons RW, Lennette EH. The development of Colorado tick fever virus within cells of the haemopoietic system. J Gen Virol 1978; 39:73.</a></li><li><a class="nounderline abstract_t">Bartelloni PJ, Tesh RB. Clinical and serologic responses of volunteers infected with phlebotomus fever virus (Sicilian type). Am J Trop Med Hyg 1976; 25:456.</a></li><li><a class="nounderline abstract_t">Sabin AB, et al. Phlebotomus (pappataci or sandfly) liver. JAMA 1944; 125:603.</a></li><li><a class="nounderline abstract_t">Abdool Gaffar MS, Seedat YK, Coovadia YM, Khan Q. The white cell count in typhoid fever. Trop Geogr Med 1992; 44:23.</a></li><li><a class="nounderline abstract_t">James J, Dutta TK, Jayanthi S. Correlation of clinical and hematologic profiles with bone marrow responses in typhoid fever. Am J Trop Med Hyg 1997; 57:313.</a></li><li><a class="nounderline abstract_t">Mallouh AA, Sa'di AR. White blood cells and bone marrow in typhoid fever. Pediatr Infect Dis J 1987; 6:527.</a></li><li><a class="nounderline abstract_t">Shin BM, Paik IK, Cho HI. Bone marrow pathology of culture proven typhoid fever. J Korean Med Sci 1994; 9:57.</a></li><li><a class="nounderline abstract_t">Sood R, Roy S, Kaushik P. Typhoid fever with severe pancytopenia. Postgrad Med J 1997; 73:41.</a></li><li><a class="nounderline abstract_t">Suyasa IG, Reka IG, Inada K, et al. Plasma endotoxin in typhoid fever. Kobe J Med Sci 1995; 41:175.</a></li><li><a class="nounderline abstract_t">Keuter M, Dharmana E, Kullberg BJ, et al. Phospholipase A2 is a circulating mediator in typhoid fever. J Infect Dis 1995; 172:305.</a></li><li><a class="nounderline abstract_t">Netea MG, Drenth JP, De Bont N, et al. A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of MRNA for TNF-alpha and IL-1 beta in whole blood cultures: its application in typhoid fever and exentric exercise. Cytokine 1996; 8:739.</a></li><li><a class="nounderline abstract_t">Keuter M, Dharmana E, Gasem MH, et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994; 169:1306.</a></li><li><a class="nounderline abstract_t">Butler T, Ho M, Acharya G, et al. Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 1993; 37:2418.</a></li><li><a class="nounderline abstract_t">Fried D, Maytal J, Hanukoglu A. The differential leukocyte count in shigellosis. Infection 1982; 10:13.</a></li><li><a class="nounderline abstract_t">Halpern Z, Averbuch M, Dan M, et al. The differential leukocyte count in adults with acute gastroenteritis. Scand J Infect Dis 1992; 24:205.</a></li><li><a class="nounderline abstract_t">Witkowska D, Czarny A, Mulczyk M. Some biological properties of outer membrane proteins of Shigella. Arch Immunol Ther Exp (Warsz) 1987; 35:759.</a></li><li><a class="nounderline abstract_t">Azim T, Islam LN, Halder RC, et al. Peripheral blood neutrophil responses in children with shigellosis. Clin Diagn Lab Immunol 1995; 2:616.</a></li><li><a class="nounderline abstract_t">al-Eissa Y, al-Nasser M. Haematological manifestations of childhood brucellosis. Infection 1993; 21:23.</a></li><li><a class="nounderline abstract_t">Crosby E, Llosa L, Miro Quesada M, et al. Hematologic changes in brucellosis. J Infect Dis 1984; 150:419.</a></li><li><a class="nounderline abstract_t">Galanakis E, Bourantas KL, Leveidiotou S, Lapatsanis PD. Childhood brucellosis in north-western Greece: a retrospective analysis. Eur J Pediatr 1996; 155:1.</a></li><li><a class="nounderline abstract_t">al-Eissa YA, Assuhaimi SA, al-Fawaz IM, et al. Pancytopenia in children with brucellosis: clinical manifestations and bone marrow findings. Acta Haematol 1993; 89:132.</a></li><li><a class="nounderline abstract_t">Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture. J Infect Dis 1986; 153:122.</a></li><li><a class="nounderline abstract_t">Kokkini G, Giotaki HG, Moutsopoulos HM. Transient hemophagocytosis in Brucella melitensis infection. Arch Pathol Lab Med 1984; 108:213.</a></li><li><a class="nounderline abstract_t">Cheers C, Young AM. Serum colony stimulating activity and colony forming cells in murine brucellosis: relationship to immunopathology. Microb Pathog 1987; 3:185.</a></li><li><a class="nounderline abstract_t">Palomera Bernal L, García Díez I, Barbudo Merino A, et al. [The reactive hemophagocytic syndrome associated with infection: a study of 3 cases]. An Med Interna 1990; 7:411.</a></li><li><a class="nounderline abstract_t">Pullen RL, Stuart BM. Tularemia. JAMA 1945; 129:495.</a></li><li><a class="nounderline abstract_t">Syrjälä H. Peripheral blood leukocyte counts, erythrocyte sedimentation rate and C-reactive protein in tularemia caused by the type B strain of Francisella tularensis. Infection 1986; 14:51.</a></li><li><a class="nounderline abstract_t">Sjöstedt A, Conlan JW, North RJ. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun 1994; 62:2779.</a></li><li><a class="nounderline abstract_t">Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990; 89:291.</a></li><li><a class="nounderline abstract_t">Bozóky G, Ruby E, Góhér I, et al. [Hematologic abnormalities in pulmonary tuberculosiss]. Orv Hetil 1997; 138:1053.</a></li><li><a class="nounderline abstract_t">ROSE HM. The clinical manifestations and laboratory diagnosis of rickettsialpox. Ann Intern Med 1949; 31:871.</a></li><li><a class="nounderline abstract_t">Klein MB, Hayes SF, Goodman JL. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect Immun 1998; 66:3410.</a></li><li><a class="nounderline abstract_t">Dumler JS. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol 2012; 64:13.</a></li><li><a class="nounderline abstract_t">Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199.</a></li><li><a class="nounderline abstract_t">Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin North Am 1998; 12:123.</a></li><li><a class="nounderline abstract_t">Hall GW, Schwartz RP. White blood cell count and differential in Rocky Mountain spotted fever. N C Med J 1979; 40:212.</a></li><li><a class="nounderline abstract_t">Musumeci S, D'Agata A, Schiliro G, Fischer A. Studies of the neutropenia in kala-azar: results in two patients. Trans R Soc Trop Med Hyg 1976; 70:500.</a></li><li><a class="nounderline abstract_t">Rai ME, Muhammad Z, Sarwar J, Qureshi AM. Haematological findings in relation to clinical findings of visceral Leishmaniasis in Hazara Division. J Ayub Med Coll Abbottabad 2008; 20:40.</a></li><li><a class="nounderline abstract_t">Pollack S, Nagler A, Liberman D, et al. Immunological studies of pancytopenia in visceral leishmaniasis. Isr J Med Sci 1988; 24:70.</a></li><li><a class="nounderline abstract_t">Marwaha N, Sarode R, Gupta RK, et al. Clinico-hematological characteristics in patients with kala azar. A study from north-west India. Trop Geogr Med 1991; 43:357.</a></li><li><a class="nounderline abstract_t">Benjamin B, Annobil SH, Bassuni WA. Diagnostic and management problems in childhood visceral leishmaniasis in south-western Saudi Arabia. Ann Trop Paediatr 1994; 14:7.</a></li><li><a class="nounderline abstract_t">Sinha R, Datta U, Sehgal S. Importance of bone marrow culture for diagnosis of Kala azar. Scand J Infect Dis 1993; 25:787.</a></li><li><a class="nounderline abstract_t">Wickramasinghe SN, Abdalla SH, Kasili EG. Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol 1987; 40:267.</a></li><li><a class="nounderline abstract_t">Badaró R, Nascimento C, Carvalho JS, et al. Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis 1994; 170:413.</a></li><li class="breakAll">Weatherall DJ, Kwiatkowski D. Hematologic manifestations of systemic diseases in children of the developing world. In: Hematology of Infancy and Childhood, 5th ed, Nathan D, Orkin (Eds), WB Saunders, Philadelphia  p.1902.</li><li><a class="nounderline abstract_t">Olliaro P, Djimdé A, Dorsey G, et al. Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg 2011; 85:619.</a></li><li><a class="nounderline abstract_t">Dale DC, Wolff SM. Studies of the neutropenia of acute malaria. Blood 1973; 41:197.</a></li><li><a class="nounderline abstract_t">Senaldi G, Vesin C, Chang R, et al. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 1994; 62:1144.</a></li></ol></div><div id="topicVersionRevision">Topic 8372 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35997401" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166617" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Neutropenia in pediatric practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32651579" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Extrapulmonary manifestations of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35571527" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pancytopenia with Development of Persistent Neutropenia Secondary to COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34848430" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Self-limiting severe neutropenia in a patient with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33604404" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3606961" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Haematologic manifestations of the human immune deficiency virus (HIV).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9290541" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7575050" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Neutropenia and bacterial infection in acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3620353" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2708831" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3142252" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2016623" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9456256" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8808719" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6318560" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Antineutrophil antibodies in infectious mononucleosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6637897" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Transient neutrophil aggregation in a patient with infectious mononucleosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2987785" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8392303" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9310503" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1331630" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Management and prevention of cytomegalovirus infection after renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20996954" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The leukocytic response of patients with experimentally induced infectious hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4688574" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Viral hepatitis and agranulocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2214880" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9305675" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Side effects of alpha interferon in chronic hepatitis C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9091802" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Hepatitis-associated aplastic anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2183887" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9141447" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1309393" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9311701" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Leukocytic response to measles</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6374033" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Polymorphonuclear leukocyte-associated antigenemia in measles: demonstration and significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7376868" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Defective bactericidal function of polymorphonuclear neutrophils in children with measles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2027167" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Polymorphonuclear and monocyte functions in measles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/778364" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Defective neutrophil motility in children with measles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6019448" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Blood leukocyte response to live measles vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13347088" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The blood picture in rubella; its place in diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13347088" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The blood picture in rubella; its place in diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2839816" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Varicella infection with profound neutropenia, multisystem involvement and no sequelae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9237695" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Early clinical and laboratory indicators of acute dengue illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7041262" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Dengue: hematologic aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13790259" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Colorado tick fever as a hematologic problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8445735" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Replication of Colorado tick fever virus within human hematopoietic progenitor cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/641533" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The development of Colorado tick fever virus within cells of the haemopoietic system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/180844" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical and serologic responses of volunteers infected with phlebotomus fever virus (Sicilian type).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Phlebotomus (pappataci or sandfly) liver</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1496717" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The white cell count in typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9311642" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Correlation of clinical and hematologic profiles with bone marrow responses in typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3615066" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : White blood cells and bone marrow in typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8068220" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Bone marrow pathology of culture proven typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9039410" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Typhoid fever with severe pancytopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8929638" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Plasma endotoxin in typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7797937" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Phospholipase A2 is a circulating mediator in typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8932986" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of MRNA for TNF-alpha and IL-1 beta in whole blood cultures: its application in typhoid fever and exentric exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8195608" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Patterns of proinflammatory cytokines and inhibitors during typhoid fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8285627" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7068229" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The differential leukocyte count in shigellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1641598" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The differential leukocyte count in adults with acute gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3334007" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Some biological properties of outer membrane proteins of Shigella.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8548543" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Peripheral blood neutrophil responses in children with shigellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449576" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Haematological manifestations of childhood brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6481187" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Hematologic changes in brucellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8750800" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Childhood brucellosis in north-western Greece: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8362601" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pancytopenia in children with brucellosis: clinical manifestations and bone marrow findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3941276" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6546508" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transient hemophagocytosis in Brucella melitensis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3509765" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Serum colony stimulating activity and colony forming cells in murine brucellosis: relationship to immunopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2103268" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : [The reactive hemophagocytic syndrome associated with infection: a study of 3 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Tularemia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3710592" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Peripheral blood leukocyte counts, erythrocyte sedimentation rate and C-reactive protein in tularemia caused by the type B strain of Francisella tularensis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8005668" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2393033" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9182273" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : [Hematologic abnormalities in pulmonary tuberculosiss].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15393018" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The clinical manifestations and laboratory diagnosis of rickettsialpox.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9632613" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22098465" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The biological basis of severe outcomes in Anaplasma phagocytophilum infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604172" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Clinical and laboratory characteristics of human granulocytic ehrlichiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9494834" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Ehrlichiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/286884" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : White blood cell count and differential in Rocky Mountain spotted fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/841653" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Studies of the neutropenia in kala-azar: results in two patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19610513" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Haematological findings in relation to clinical findings of visceral Leishmaniasis in Hazara Division.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2833465" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Immunological studies of pancytopenia in visceral leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1812600" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Clinico-hematological characteristics in patients with kala azar. A study from north-west India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7516138" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Diagnostic and management problems in childhood visceral leishmaniasis in south-western Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8052823" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Importance of bone marrow culture for diagnosis of Kala azar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3558859" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Ultrastructure of bone marrow in patients with visceral leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035028" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035028" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976561" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4575057" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Studies of the neutropenia of acute malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8132319" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
